Phathom Pharmaceuticals(PHAT) - 2024 Q1 - Earnings Call Presentation

FIRST QUARTER 2024 EARNINGS CONFERENCE CALL MAY 2024 NASDAQ: PHAT Today's Agenda Business Update Terrie Curran, President & Chief Executive Officer US Commercial Launch Progress Martin Gilligan, Chief Commercial Officer First Quarter 2024 Results Molly Henderson, Chief Financial & Business Officer Closing Remarks Terrie Curran, President & Chief Executive Officer Question & Answer Terrie Curran, President & Chief Executive Officer Martin Gilligan, Chief Commercial Officer Molly Henderson, Chief Financial & ...